News/ News/ Oncology Mustang Bio’s first-of-a-kind CAR-T starts trials Phil Taylor CAR T, Mustang Bio, myeloma 0 Comment US biotech Mustang Bio says that an investigator-led trial of its CAR-T therapy for multiple myeloma – the Share X Mustang Bio’s first-of-a-kind CAR-T starts trials https://pharmaphorum.com/news/mustang-bio-car-t-starts-trials/
